Application Note: CAR-T Cell Release Testing with qPCR and dPCR

Chimeric Antigen Receptor (CAR) T-cell therapy is a groundbreaking approach in cancer immunotherapy and in autoimmune disease. In this application note, we detail the characterization and functionality assessment of CAR-T cells using both quantitative PCR (qPCR) and digital PCR (dPCR). 

These advanced molecular techniques provide complementary insights, enhancing the quality control testing essential for ensuring the efficacy and safety of CAR-T cell therapies. Furthermore, we highlight the utility of our kits in streamlining the analysis process by facilitating efficient and accurate evaluation of CAR-T cell products.

Please fill out the short form below to download the application note:



What genetic analysis solution are you interested in? Check all that apply.
How can we help you?
What is your purchasing time frame?

I would like Thermo Fisher Scientific (including its affiliates) to add me to a list to receive information about events, products, services and promotions which Thermo Fisher believes may be of interest to me via the following channels:

 

I can withdraw my consent and unsubscribe at any time by e-mailing reply@thermofisher.com

I acknowledge Thermo Fisher Scientific (including its affiliates) will process my personal information according to its Privacy Policy, which includes information about my rights.